WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5'0101 Infant (under 12 months) mortality rate: 1002
GDP / capita (US$): 7'5381 Child (under 5 years) mortality rate: 1642

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 21'472  20'821  20'180  19'549  18'927  13'925  10'334  7'637 
Births 949  934  920  906  891  709  548  405 
Surviving infants 859  844  829  815  800  619  465  341 
Pop. less than 5 years 4'021  3'966  3'895  3'796  3'705  2'731  2'055  1'491 
Pop. less than 15 years 10'199  9'930  9'647  9'346  9'070  6'633  4'905  3'550 
Female 15-49 years 4'786  4'627  4'477  4'339  4'194  3'112  2'287  1'705 

Number of reported case

(Click for retrospective incidence data for Angola)
Diphtheria 20  15  64 
Japanese encephalitis
Measles 8'523  4'458  1'449  1'190  2'807  2'219  29'069  29'656 
Mumps
Pertussis 1'259  1'554  2'539  1'127  560  14'420  54'126 
Polio* 33  29  115  32 
Rubella 36  65  24  38  10 
Rubella (CRS)
Tetanus (neonatal) 33  75  13  66  131  959  541 
Tetanus (total) 360  543  953  490  675  1'826  1'185 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Angola)
Vaccine year result method % card seen                                                
BCG 2000  69  MICS   34  85  87  88  93  83  56 
DTP1 2000  56  MICS   34  97  99*  99*  99*  93  44 
DTP3 2000  34  MICS   34  93  91  86  91  73  31 
HepB_BD         
HepB3          93  91  86  91  73 
Hib3          93  91  86  91  73 
JapEnc         
MCV 2000  53  MICS   34  91  97  88  93  77 
MCV2         
PCV1          44 
PCV3         
Pol3 2000  63  MICS   34  80  88  85  92  73  33 
Rota1         
Rota_last         
Rubella1         
TT2plus 2000  62  MICS   34  83  78  79  87  77 
PAB         
VAD1          19  21  18  19  14 
YFV 1995  21  MICS   43  49  63  64  40  40  29 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Angola)
BCG 85  87  88  93  83  56  48 
DTP1 97  99  99  99  93  44  48 
DTP3 93  91  86  91  73  31  24 
HepB3 93  91  86  91  73 
HepB_BD
Hib3 93  91  86  91  73 
MCV 91  97  88  93  77  41  38 
MCV2
PAB 75  72  70  75  88  60  34 
PnC3
Pol3 80  88  85  92  73  33  23 
Rota_last
YFV 49  63  64  40  40  50 

Number of districts in the country 166  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 52
From 80 to 89% 14
From 50 to 79% 29
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 9 years; +1, +5 months; Yes From September 2015
IPV 6 months; From September 2015
Measles 9 months; Yes
OPV Birth; 2, 4, 6 months; Yes
Pneumo_conj 2, 4, 6 months; Yes
Rotavirus 2, 4 months; From April 2014
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 9 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011- 2015  2010-2015  2009 - 2012  2009-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 157  123  120  79    160  160 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No       

System performance

Total Nº districts in country number 166  165  164  164  164  164  164 
Nº districts with DTP3 coverage >=80% number 109  112  96  99  65  76  14 
% of districts with DTP3 coverage >=80% From 0 to 100% 66  68  59  60  40  46 
Nº districts with measles (MCV1) coverage >=95% number 99  87  74  81  53  53   
% of districts with MCV1 coverage >=95% From 0 to 100% 60  53  45  49  32  32   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  No  No  Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 55  100    29  100    18 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.